derinet® Switzerland
Product names from:
VontobelSVSP
Back

Express VONCERT on AbbVie Inc, Bristol-Myers Squibb, Fresenius & KGaA, Gilead Sciences (Quanto EUR)

  • Valor 46974986
  • ISIN CH0469749862
  • Symbol
sustainable
Bid (indicative)%
Ask (indicative)%
CurrencyEUR
Price on
  • Quanto
  • Barrier observation at the end
  • Autocallable
  • sustainable
AbbVie IncUSD 
Bristol-Myers Squibb Co.USD 
Fresenius SE & Co. KGaAEUR 
Gilead Sciences Inc.USD 
Please note that this is an indication.

Documents

Life cycle
Initial fixing26/03/2019
Payment date02/04/2019
Last trading day28/09/2020
Final fixing28/09/2020
Redemption05/10/2020

Current price information

Intraday1 week1 monthSince emission
until
I18N_ProductUnderlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 73.63USD 63.61USD 51.68
USD 51.61USD 37.99USD 30.87
EUR 42.24EUR 37.82EUR 30.73
USD 63.99USD 51.30USD 41.68

No chart available

Life cycle
Initial fixing26/03/2019
Payment date02/04/2019
Last trading day28/09/2020
Final fixing28/09/2020
Redemption05/10/2020
Figures
Product typeExpress VONCERT
SSPA categorisationExpress Certificate
Issue price100.00%
Reference currencyEUR
QuantoYes
BarrierUSD 51.68
Barrier observationat the end
Underlying/
ISIN of underlying
AbbVie Inc
US00287Y1091
Spot reference priceUSD 79.51
COSINo
ListingNone
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program